GSK stock higher on revised long-term guidance (GSK:NYSE)
3 days ago · GSK shares added ~6% in London trading on Wednesday after the British drugmaker lifted its 2031 outlook and announced a new share buyback program alongside …
OFF
GSK Stock Higher On Revised Long-term Guidance (GSK:NYSE)
2 weeks from now
3 days ago · GSK shares added ~6% in London trading on Wednesday after the British drugmaker lifted its 2031 outlook and announced a new share buyback program alongside …
seekingalpha.com
OFF
GSK Stock Jumps On Long-Term Outlook Boost, $2.5B Share …
2 weeks from now
3 days ago · GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of …
investopedia.com
OFF
GSK Raises Long-term Guidance, Announces Buybacks - MSN
2 weeks from now
GSK shares added ~6% in London trading on Wednesday after the British drugmaker lifted its 2031 outlook and announced a new share buyback program alongside better-than-expected …
msn.com
OFF
GSK Stock Surges After Bumping Its 2031 Outlook To North Of …
2 weeks from now
2 days ago · GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 billion in sales. GSK delivered a mixed fourth-quarter …
investors.com
OFF
GSK Lifts Long-Term Outlook On Drug Pipeline, Buys Back Shares
2 weeks from now
3 days ago · (Bloomberg) -- GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline.Most Read from …
yahoo.com
OFF
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion …
2 weeks from now
3 days ago · Guidance: GSK expects 2025 sales to grow ... The pharma giant boosted its long-term growth outlook and now expects over 40 ... At last check on Wednesday, GSK stock was …
benzinga.com
OFF
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50
2 weeks from now
2 days ago · GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 billion in sales.
yahoo.com
OFF
Why GSK Stock Is Surging Today - Yahoo Finance
2 weeks from now
3 days ago · GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. GSK’s …
yahoo.com
OFF
GSK Plc (GSK) Q4 2024 Earnings Call Transcript - Seeking Alpha
2 weeks from now
3 days ago · The reduction reflected a £1.8 billion charge relating to the resolution of the Zantac litigation and a higher CCL charge driven by the improved long-term outlook for our HIV business.
seekingalpha.com
OFF
GSK Up Over 7%, On Track For Largest Percent Increase
2 weeks from now
3 days ago · GSK plc Sponsored ADR (GSK) is currently at $37.41, up $2.57 or 7.38% --Would be highest close since Oct. 29, 2024, when it closed at $38.17 --On pace for largest percent …
morningstar.com
OFF
GSK (NYSE:GSK) Releases FY 2025 Earnings Guidance - MarketBeat
2 weeks from now
3 days ago · GSK has a 52 week low of $31.72 and a 52 week high of $45.92. The company has a quick ratio of 0.53, a current ratio of 0.81 and a debt-to-equity ratio of 0.98. GSK …
marketbeat.com
OFF
GSK Lifts Long-term Outlook; Eyes 12 Major Launches From 2025
2 weeks from now
Jan 31, 2024 · The management also raised GSK’s long-term outlook, expecting sales and adj. operating profit to grow by more than 7% and 11% in CAGR terms in 2021–2026, respectively.
seekingalpha.com
OFF
Why GSK (GSK) Is A Top Momentum Stock For The Long-Term
2 weeks from now
Feb 12, 2024 · Shares of GSK has seen some interesting price action recently; the stock is up 2.9% over the past one week and up 4.5% over the past four weeks. And in the last one-year …
yahoo.com
OFF
GSK Upgrades Long-term Sales Target; But Arexvy's Struggles Are ...
2 weeks from now
3 days ago · GSK PLC (LSE:GSK, NYSE:GSK) has raised its long-term revenue forecast, now expecting sales to exceed £40 billion by 2031, up from its previous £38 billion target. The …
proactiveinvestors.com
OFF
GSK (GSK) Stock Price, News & Analysis - MarketBeat
2 weeks from now
Jan 29, 2025 · In Q2 - Q4 of 2022, the company's stock price dropped nearly 40% concerning long-term shareholders. This stock has underperformed the broader market and many of its …
marketbeat.com
OFF
Analysts Set GSK Plc (NYSE:GSK) Target Price At $43.25 - MarketBeat
2 weeks from now
Feb 1, 2025 · Check Out Our Latest Analysis on GSK. GSK Stock Performance. Shares of GSK stock traded down $0.16 during trading hours on Friday, hitting $35.20. 5,112,110 shares of …
marketbeat.com
OFF
GSK (GSK) Stock Forecast And Price Target 2025 - MarketBeat
2 weeks from now
2 days ago · GSK's stock has a 12-month high of $45.92, which may indicate that it is currently trading closer to its peak, potentially limiting upside for new investors. The company has a …
marketbeat.com
FAQs about GSK stock higher on revised long-term guidance (GSK:NYSE) Coupon?
Why did GSK shares rise 6% in London?
Why did GSK shares drop on Wednesday?
Will GSK raise its guidance to £40 billion by 2031?
How will GSK's business perform this year?
What was GSK's stock price at the start of the year?
How did GSK perform in 2024?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
